Literature DB >> 14769400

The beta-amyloid-related proteins presenilin 1 and BACE1 are axonally transported to nerve terminals in the brain.

Jin G Sheng1, Donald L Price, Vassilis E Koliatsos.   

Abstract

In this study, we show that removal of entorhinal cortex (ERC) afferents to hippocampus reduces levels of presenilin 1 (PS1) in the dentate gyrus of APPswe/PS1DeltaE9 transgenic (Tg) mice. PS1 immunoreactivity on the deafferented dentate gyrus decreases by approximately 25% and 50%, 2 and 4 weeks post-lesion compared to the contralateral side; by Western blotting, there is an approximately 40% decrease of the 43 kDa (full length) PS1 and an approximately 80% decrease of the 28 kDa (N-terminal fragment) PS1 on the lesioned dentate gyrus. Levels of beta-site APP Cleavage Enzyme 1 (BACE1) immunoreactivity also decrease by approximately 50% and 65% 2 and 4 weeks post-lesion. Together, these data demonstrate that PS1 and BACE1 are transported from the entorhinal cortex to the hippocampus via axons of the perforant pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14769400     DOI: 10.1016/j.expneurol.2003.08.018

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  20 in total

1.  β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation.

Authors:  Yan Cai; Kun Xiong; Xue-Mei Zhang; Huaibin Cai; Xue-Gang Luo; Jia-Chun Feng; Richard W Clough; Robert G Struble; Peter R Patrylo; Yaping Chu; Jeffrey H Kordower; Xiao-Xin Yan
Journal:  Eur J Neurosci       Date:  2010-08-18       Impact factor: 3.386

2.  The presenilin loop region is essential for glycogen synthase kinase 3 β (GSK3β) mediated functions on motor proteins during axonal transport.

Authors:  Rupkatha Banerjee; Zoe Rudloff; Crystal Naylor; Michael C Yu; Shermali Gunawardena
Journal:  Hum Mol Genet       Date:  2018-09-01       Impact factor: 6.150

3.  Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development.

Authors:  Xue-Mei Zhang; Yan Cai; Kun Xiong; Huaibin Cai; Xue-Gang Luo; Jia-Chun Feng; Richard W Clough; Robert G Struble; Peter R Patrylo; Xiao-Xin Yan
Journal:  Eur J Neurosci       Date:  2009-12-10       Impact factor: 3.386

Review 4.  Nanoparticles in the brain: a potential therapeutic system targeted to an early defect observed in many neurodegenerative diseases.

Authors:  Shermali Gunawardena
Journal:  Pharm Res       Date:  2013-04-27       Impact factor: 4.200

Review 5.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

6.  Presenilin controls kinesin-1 and dynein function during APP-vesicle transport in vivo.

Authors:  Shermali Gunawardena; Ge Yang; Lawrence S B Goldstein
Journal:  Hum Mol Genet       Date:  2013-05-24       Impact factor: 6.150

7.  UV irradiation accelerates amyloid precursor protein (APP) processing and disrupts APP axonal transport.

Authors:  Angels Almenar-Queralt; Tomas L Falzone; Zhouxin Shen; Concepcion Lillo; Rhiannon L Killian; Angela S Arreola; Emily D Niederst; Kheng S Ng; Sonia N Kim; Steven P Briggs; David S Williams; Lawrence S B Goldstein
Journal:  J Neurosci       Date:  2014-02-26       Impact factor: 6.167

8.  Asynchronous evolutionary origins of Aβ and BACE1.

Authors:  D Blaine Moore; Madelyn A Gillentine; Nathalie M Botezatu; Kyle A Wilson; Ashley E Benson; James A Langeland
Journal:  Mol Biol Evol       Date:  2013-12-19       Impact factor: 16.240

9.  Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic mice.

Authors:  Matthew J Chiocco; Laura Shapiro Kulnane; Linda Younkin; Steve Younkin; Geneviève Evin; Bruce T Lamb
Journal:  J Biol Chem       Date:  2004-09-27       Impact factor: 5.157

10.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.